Target Name: BIN2
NCBI ID: G51411
Review Report on BIN2 Target / Biomarker Content of Review Report on BIN2 Target / Biomarker
BIN2
Other Name(s): Bridging integrator-2 | BIN2_HUMAN | breast cancer associated protein BRAP1 | Bridging integrator 2, transcript variant 1 | BIN2 variant 1 | breast cancer-associated protein 1 | Breast cancer-associated protein 1 | Bridging integrator 2 | Bridging integrator 2 isoform 1 | bridging integrator 2 | BRAP-1 | Breast cancer associated protein BRAP1

BIN2: Key Regulator of Brain Communication

BIN2, short for Bridging Integrator-2, is a protein that plays a critical role in the development and maintenance of normal brain function. It is a key regulator of the bridging integrator complex, which is responsible for ensuring the proper communication between different parts of the brain. BIN2 is also a drug target and has been identified as a potential biomarker for various neurological and psychiatric disorders.

The bridging integrator complex is a protein complex that is composed of several different proteins that work together to regulate the movement of electrical signals in the brain. This complex is responsible for ensuring that signals are properly transmitting between different areas of the brain, allowing for proper communication and efficient function.

BIN2 is one of the proteins that is part of the bridging integrator complex. It is a small, transmembrane protein that is composed of 114 amino acids. It has a unique structure that allows it to interact with other proteins in the bridging integrator complex.

BIN2 function

BIN2 is involved in several different processes in the brain, including the regulation of neurotransmitter release, the modulation of ion channels, and the control of brain temperature. It is also involved in the regulation of the movement of small molecules, such as drugs, into the brain.

One of the key functions of BIN2 is its role as a negative regulator of the bridging integrator complex. This means that it works to keep the complex in a state of balance, ensuring that signals are properly transmitting between different areas of the brain.

BIN2 is also involved in the regulation of neurotransmitter release. When neurons release neurotransmitters, BIN2 can regulate this process, thereby affecting communication between neurons.

Another important role is that BIN2 can regulate ion channels. When the ion channels on the neuron cell membrane are opened, BIN2 can regulate the closing of the ion channels, thereby affecting the potential changes of the neuron cells.

In addition, BIN2 can also regulate changes in brain temperature. When neuronal activity increases, BIN2 can regulate changes in brain temperature, thereby ensuring the normal physiological function of neurons.

Pharmacological significance of BIN2

BIN2 is a drug target because of its involvement in the regulation of neurotransmitter release and the regulation of ion channels. Drugs that target these processes have been shown to be effective in treating various neurological and psychiatric disorders.

For example, drugs that target the regulation of neurotransmitter release have been shown to be effective in treating depression, anxiety, and PTSD. Additionally, drugs that target the regulation of ion channels have been shown to be effective in treating epilepsy and certain types of cancer..

BIN2 has also been shown to be a potential biomarker for certain neurological disorders. For example, BIN2 has been shown to be reduced in individuals with depression and anxiety disorders. Additionally, BIN2 has been shown to be reduced in individuals with certain types of cancer, which may indicate that it has a role in the regulation of cancer cell growth and metastasis.

Conclusion

BIN2 is a protein that plays a critical role in the development and maintenance of normal brain function. It is involved in several different processes in the brain, including the regulation of neurotransmitter release, the modulation of ion channels, and the regulation of brain temperature. BIN2 is also involved in the regulation of the bridging integrator complex, which is responsible for ensuring the proper communication between different parts of the brain.

BIN2 is a drug target because of its involvement in the regulation of neurotransmitter release and the regulation of ion channels. It is also a potential biomarker for various neurological and psychiatric disorders. Further research is needed to fully understand the role of BIN2 in brain function and its potential as a drug target.

Protein Name: Bridging Integrator 2

Functions: Promotes cell motility and migration, probably via its interaction with the cell membrane and with podosome proteins that mediate interaction with the cytoskeleton. Modulates membrane curvature and mediates membrane tubulation. Plays a role in podosome formation. Inhibits phagocytosis

The "BIN2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BIN2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

BIN3 | BIN3-IT1 | Biogenesis of lysosome-related organelles complex-1 | BIRC2 | BIRC3 | BIRC5 | BIRC6 | BIRC7 | BIRC8 | BISPR | BIVM | BIVM-ERCC5 | BLACAT1 | BLACE | BLCAP | BLID | BLK | BLM | BLMH | BLNK | BLOC-1 (biogenesis of lysosome-related organelles complex 1) | BLOC1S1 | BLOC1S1-RDH5 | BLOC1S2 | BLOC1S3 | BLOC1S4 | BLOC1S5 | BLOC1S5-TXNDC5 | BLOC1S6 | BLTP1 | BLTP2 | BLTP3A | BLTP3B | BLVRA | BLVRB | BLZF1 | BMAL1 | BMAL2 | BMAL2-AS1 | BMERB1 | BMF | BMI1 | BMP1 | BMP10 | BMP15 | BMP2 | BMP2K | BMP3 | BMP4 | BMP5 | BMP6 | BMP7 | BMP8A | BMP8B | BMPER | BMPR1A | BMPR1B | BMPR1B-DT | BMPR2 | BMS1 | BMS1P1 | BMS1P10 | BMS1P14 | BMS1P15 | BMS1P17 | BMS1P18 | BMS1P2 | BMS1P20 | BMS1P21 | BMS1P22 | BMS1P4 | BMS1P7 | BMS1P8 | BMT2 | BMX | BNC1 | BNC2 | BNC2-AS1 | BNIP1 | BNIP2 | BNIP3 | BNIP3L | BNIP5 | BNIPL | BOC | BOD1 | BOD1L1 | BOD1L2 | BOK | BOK-AS1 | BOLA1 | BOLA2 | BOLA2B | BOLA3 | BOLA3-DT | BOLL | Bombesin receptor | Bone morphogenetic protein (BMP) | Bone Morphogenetic Protein Receptor | Bone Morphogenetic Protein Receptor Type I